Enhancing 1p/19q Classification in Brain Gliomas Using Isocitrate Dehydrogenase Status: A Deep Learning Study
- 7 May 2026
- journal article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (11) , 2759-2766
Abstract
IDH mutation & 1p/19q codeletion are critical biomarkers for glioma diagnosis & therapy. 1p/19q codeletion occurs exclusively in IDH-mutated gliomas. In this study, we developed a 2-stage, non-invasive, MRI-based deep learning method that leverages IDH status to enhance 1p/19q predictions. Multi-contrast brain tumor MRI & genomic information were obtained from five publicly available (TCIA, UCSF, EGD, UPenn & LGG), and three in-house/collaborator institutions (UTSW, NYU, UWM). Subjects were screened for the availability of IDH & 1p/19q status as well as T1, T1CE, T2, FLAIR MR images. For training purposes, missing T1 and FLAIR contrasts for the LGG database were generated using an in-house multi-contrast simulator. Two separate U-Nets were developed for 1p/19q-classification: a multi-contrast network (MC-Net) and a T2w-only network (T2-Net). A separate U-Net was developed for IDH classification (IDH-net). A total of 2044 subjects were used in training and testing IDH-Net, and 1426 subjects were used in training and testing the 1p/19q models. The IDH-Net was trained using subjects from TCIA, UTSW, and UPenn. The 1p/19q networks were trained using subjects from TCIA, UTSW, and LGG. The trained networks were tested on true held-out cases from NYU, UWM, EGD, and UCSF. In the 2-stage approach, subjects were initially classified for IDH status using IDH-Net. Predicted IDH-wildtype cases default to 1p/19q non-codeleted. Then the IDH-mutated cases were further classified for 1p/19q status using the 1p/19q-networks. IDH-Net achieved a classification accuracy of 93.7%. 1p/19q MC-Net & T2-Net achieved classification accuracies of 86.5% & 86.0%, respectively. In the 2-stage approach, 1p/19q MC-Net and T2-Net achieved accuracies of 91.5% & 91.2% respectively, improving the classification accuracy by ∼5%. This study demonstrates the effectiveness of leveraging IDH status to enhance 1p/19q classification. A ∼5% increase in classification accuracy was achieved when using the 2-stage approach, using IDH-Net to gate 1p/19q predictions. The developed method offers a reliable, non-invasive approach to determine important biomarkers for glioma diagnosis.Keywords
Funding Information
- NIH/NCI (R01CA260705)
This publication has 30 references indexed in Scilit:
- Multi-task glioma segmentation and IDH mutation and 1p19q codeletion classification via a deep learning model on multimodal MRIMeta-Radiology, 2025
- The Erasmus Glioma Database (EGD): Structural MRI scans, WHO 2016 subtypes, and segmentations of 774 patients with gliomaData in Brief, 2021
- Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in gliomaComputerized Medical Imaging and Graphics, 2021
- Machine Learning in Medical ImagingJournal of the American College of Radiology, 2018
- Radiomics Strategy for Molecular Subtype Stratification of Lower‐Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRIJournal of Magnetic Resonance Imaging, 2018
- Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine IntelligenceJournal of Digital Imaging, 2017
- Molecular classification of gliomas2016
- The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information RepositoryJournal of Digital Imaging, 2013
- Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomasCancer Genetics and Cytogenetics, 2008
- Loss of Heterozygosity of Chromosome 10p in Human GliomasGenomics, 1996